Brinton Pharma triples production of favipiravir

Brinton Pharmaceuticals informed that it has more than tripled up the production of Faviton (Favipiravir 400) tablets. Favipiravir is used as an oral antiviral therapy for mild to moderate cases of COVID-19. It has also increased the production of additional drugs Scabover & Iverbond (Ivermectin 12 mg) Tablet and Doxybond LB & Briodox (Doxycycline) Tablet which are also used towards the treatment of COVID-19.

The company said that it will increase Favipiravir’s production from 15 lakh to 50 lakh quantity. Brinton is providing Faviton at MRP Rs 790/ 10 tablets.

Rahul Darda, CMD, Brinton Pharmaceuticals says, “We are saddened by the way the country is battling the present wave. The end consumer or patient should be least worried about these matters and should only focus on getting better. Towards trying to improve the situation, we wanted to do our bit. By taking this call of tripling up production we will be able to help the end patient by getting the medicine available easily. We hope this helps the masses at large”

Favipiravir is used to treat mild to moderate cases of COVID-19. Brinton had launched Favipiravir in May 2020.